Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. RYHIX: which is better?

Bottom line

FHLC vs RYHIX: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 80% by weight.

But FHLC is far broader, holding 337 positions to 135 for RYHIX, so beyond the top names it adds exposure RYHIX doesn't have.

FHLC is cheaper at 0.084% vs 1.38% — a difference of $130 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +5.1% for RYHIX (reporting dates differ).

Updated Nov 19, 2026

FHLC vs RYHIX side by side

FHLCRYHIX
TypeETFMutual fund
Fund familyFidelityGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%1.38%
Annual cost per $10k$8.4$138
10-yr cost on $10k (prospectus)$108$1,709
Max front loadNone—
12b-1 fee0%0%
1-yr return+2.6%+14.4%
5-yr return (annualized)+7.2%+5.1%
10-yr return (annualized)+8.8%+7.9%
Best quarter+16.4%+18.7%
Worst quarter−13.1%−14.4%
Net assets (fund)$3.3B$19.4M
Number of holdings337135
Portfolio turnover3%244%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCRYHIXDifference
2024+2.6%+0.6%+2.0%
2023+2.5%+5.8%−3.4%
2022−5.5%−11.6%+6.2%
2021+20.4%+19.2%+1.1%
2020+18.1%+18.9%−0.8%
2019+21.9%+22.8%−0.8%
2018+5.5%+1.6%+4.0%
2017+23.3%+23.5%−0.2%
2016−3.3%−9.4%+6.0%

Source: Fund prospectus bar charts

Holdings overlap

23 of FHLC's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingFHLCRYHIX
Eli Lilly & Co13.35%3.63%
Johnson & Johnson8.93%2.88%
AbbVie Inc6.42%2.52%
UnitedHealth Group Inc5.44%2.22%
Merck & Co Inc4.66%2.04%
Thermo Fisher Scientific Inc3.09%1.61%
Amgen Inc3.00%1.56%
Abbott Laboratories2.66%1.42%
Gilead Sciences Inc2.34%1.39%
Pfizer Inc2.06%1.25%
Bristol-Myers Squibb Co1.93%1.22%
CVS Health Corp1.92%1.31%
Intuitive Surgical Inc1.82%1.31%
Danaher Corp1.80%1.30%
Vertex Pharmaceuticals Inc1.76%1.34%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between FHLC and RYHIX?
FHLC (Fidelity MSCI Health Care Index ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 80% by weight. But FHLC is far broader, holding 337 positions to 135 for RYHIX, so beyond the top names it adds exposure RYHIX doesn't have.
Which is cheaper, FHLC or RYHIX?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and RYHIX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.